DK1107795T3 - Thiomolybdat associeret med mindst ét carbohydrat og dets anvendelse til forebyggelse eller behandling af sygdomme kendetegnet ved aberrerende vascularisation, såsom cancer, maculadegeneration af våd type, rheumatoid arthritis - Google Patents
Thiomolybdat associeret med mindst ét carbohydrat og dets anvendelse til forebyggelse eller behandling af sygdomme kendetegnet ved aberrerende vascularisation, såsom cancer, maculadegeneration af våd type, rheumatoid arthritisInfo
- Publication number
- DK1107795T3 DK1107795T3 DK99952903T DK99952903T DK1107795T3 DK 1107795 T3 DK1107795 T3 DK 1107795T3 DK 99952903 T DK99952903 T DK 99952903T DK 99952903 T DK99952903 T DK 99952903T DK 1107795 T3 DK1107795 T3 DK 1107795T3
- Authority
- DK
- Denmark
- Prior art keywords
- prevention
- treatment
- cancer
- thiomolybdate
- carbohydrate
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K33/00—Medicinal preparations containing inorganic active ingredients
- A61K33/24—Heavy metals; Compounds thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/28—Compounds containing heavy metals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K33/00—Medicinal preparations containing inorganic active ingredients
- A61K33/24—Heavy metals; Compounds thereof
- A61K33/34—Copper; Compounds thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K33/00—Medicinal preparations containing inorganic active ingredients
- A61K33/24—Heavy metals; Compounds thereof
- A61K33/243—Platinum; Compounds thereof
Landscapes
- Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Epidemiology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Inorganic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Heart & Thoracic Surgery (AREA)
- Rheumatology (AREA)
- Pain & Pain Management (AREA)
- Cardiology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Medicinal Preparation (AREA)
- Compounds Of Unknown Constitution (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US9910398P | 1998-09-04 | 1998-09-04 | |
US10175998P | 1998-09-25 | 1998-09-25 | |
PCT/US1999/020374 WO2000013712A2 (en) | 1998-09-04 | 1999-09-03 | Methods and compositions for the prevention or treatment of cancer |
Publications (1)
Publication Number | Publication Date |
---|---|
DK1107795T3 true DK1107795T3 (da) | 2003-03-24 |
Family
ID=26795562
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
DK99952903T DK1107795T3 (da) | 1998-09-04 | 1999-09-03 | Thiomolybdat associeret med mindst ét carbohydrat og dets anvendelse til forebyggelse eller behandling af sygdomme kendetegnet ved aberrerende vascularisation, såsom cancer, maculadegeneration af våd type, rheumatoid arthritis |
Country Status (14)
Country | Link |
---|---|
EP (1) | EP1107795B1 (ja) |
JP (1) | JP2002524426A (ja) |
KR (1) | KR100702279B1 (ja) |
CN (1) | CN100548383C (ja) |
AT (1) | ATE228375T1 (ja) |
AU (1) | AU773848B2 (ja) |
CA (1) | CA2341752A1 (ja) |
DE (1) | DE69904203T2 (ja) |
DK (1) | DK1107795T3 (ja) |
ES (1) | ES2188261T3 (ja) |
IL (1) | IL141550A0 (ja) |
NZ (1) | NZ510038A (ja) |
PT (1) | PT1107795E (ja) |
WO (1) | WO2000013712A2 (ja) |
Families Citing this family (14)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6703050B1 (en) | 1998-09-04 | 2004-03-09 | The Regents Of The University Of Michigan | Methods and compositions for the prevention or treatment of cancer |
US20070292533A1 (en) * | 2002-05-24 | 2007-12-20 | Regents Of The University Of Michigan | Copper lowering treatment of autoimmune diseases |
US6855340B2 (en) * | 2002-05-24 | 2005-02-15 | Regents Of The University Of Michigan | Copper lowering treatment of inflammatory and fibrotic diseases |
US7189865B2 (en) * | 2002-07-23 | 2007-03-13 | Attenuon, Llc | Thiomolybdate analogues and uses thereof |
CN1688303A (zh) | 2002-07-23 | 2005-10-26 | 密歇根大学董事会 | 用于抗血管发生疗法的四硫代钼酸四丙铵及相关化合物 |
MXPA05012722A (es) | 2003-05-27 | 2006-05-25 | Attenuon Llc | Analogos de tiotungstato y sus usos. |
AU2005217623A1 (en) * | 2004-02-24 | 2005-09-09 | Attenuon Llp | Inhibition of superoxide dismutase by tetrathiomolybdate: identification of new anti-angiogenic and antitumor agents |
WO2007084818A2 (en) * | 2006-01-10 | 2007-07-26 | Pipex, Inc. | Pharmaceutical compositions and methods to achieve and maintain a targeted and stable copper status and prevent and treat copper-related central nervous system diseases |
WO2009009622A2 (en) * | 2007-07-09 | 2009-01-15 | Pipex Pharmaceuticals, Inc. | Pharmaceutical compositions, including attm, and methods to achieve and maintain a targeted and stable copper status and prevent and treat copper-related central nervous system diseases |
KR100972355B1 (ko) * | 2008-05-08 | 2010-07-26 | 고려전자주식회사 | 순간식 가스보일러의 온수공급라인용 써모밸브조립체 |
GB201005394D0 (en) * | 2010-03-30 | 2010-05-12 | Magnus Intellectual Property Ltd | Therapy |
US10478455B2 (en) | 2010-03-30 | 2019-11-19 | Ucl Business Ltd | Therapeutic use of tetrathiomolybdate |
US20160220500A1 (en) * | 2014-11-14 | 2016-08-04 | Kent State University | Targeting Intracellular Copper Ions for Inhibiting Angiogenesis Using Nanoparticles of Ternary Inorganic Metal Sulfide M1M2S4 (M1, independently, is Mg, Ca, Mn, Fe, or Zn; M2 = Mo or W) Compounds to Treat Metastatic Cancer |
CN108634322A (zh) * | 2018-05-16 | 2018-10-12 | 刘华 | 一种预防和调理癌症的方法 |
-
1999
- 1999-09-03 PT PT99952903T patent/PT1107795E/pt unknown
- 1999-09-03 DE DE69904203T patent/DE69904203T2/de not_active Expired - Lifetime
- 1999-09-03 ES ES99952903T patent/ES2188261T3/es not_active Expired - Lifetime
- 1999-09-03 IL IL14155099A patent/IL141550A0/xx unknown
- 1999-09-03 AU AU64960/99A patent/AU773848B2/en not_active Ceased
- 1999-09-03 JP JP2000568518A patent/JP2002524426A/ja active Pending
- 1999-09-03 WO PCT/US1999/020374 patent/WO2000013712A2/en active IP Right Grant
- 1999-09-03 DK DK99952903T patent/DK1107795T3/da active
- 1999-09-03 CN CNB998117331A patent/CN100548383C/zh not_active Expired - Fee Related
- 1999-09-03 EP EP99952903A patent/EP1107795B1/en not_active Expired - Lifetime
- 1999-09-03 NZ NZ510038A patent/NZ510038A/en not_active IP Right Cessation
- 1999-09-03 KR KR1020017002840A patent/KR100702279B1/ko not_active IP Right Cessation
- 1999-09-03 AT AT99952903T patent/ATE228375T1/de not_active IP Right Cessation
- 1999-09-03 CA CA002341752A patent/CA2341752A1/en not_active Abandoned
Also Published As
Publication number | Publication date |
---|---|
PT1107795E (pt) | 2003-04-30 |
CN1457261A (zh) | 2003-11-19 |
EP1107795B1 (en) | 2002-11-27 |
AU773848B2 (en) | 2004-06-10 |
EP1107795A2 (en) | 2001-06-20 |
CN100548383C (zh) | 2009-10-14 |
ES2188261T3 (es) | 2003-06-16 |
CA2341752A1 (en) | 2000-03-16 |
DE69904203D1 (de) | 2003-01-09 |
WO2000013712A3 (en) | 2000-09-28 |
AU6496099A (en) | 2000-03-27 |
IL141550A0 (en) | 2002-03-10 |
WO2000013712A2 (en) | 2000-03-16 |
JP2002524426A (ja) | 2002-08-06 |
ATE228375T1 (de) | 2002-12-15 |
KR100702279B1 (ko) | 2007-04-02 |
KR20010082190A (ko) | 2001-08-29 |
DE69904203T2 (de) | 2003-08-14 |
NZ510038A (en) | 2003-10-31 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CY1123084T1 (el) | Θεραπεια των ασθενειων αποθηκευσης γλυκογονου τυπου ιι | |
DK1107795T3 (da) | Thiomolybdat associeret med mindst ét carbohydrat og dets anvendelse til forebyggelse eller behandling af sygdomme kendetegnet ved aberrerende vascularisation, såsom cancer, maculadegeneration af våd type, rheumatoid arthritis | |
IL195328A0 (en) | Antibodies binding to anionic phospholipids and aminophospholipids and their use in the preparation of pharmaceutical compositions for treating viral infections | |
HUT76970A (hu) | Készítmény az érrendszer specifikus koagulálásához | |
NZ332721A (en) | Use of bactericidal/permeability increasing (BPI) protein sometimes in conjunction with a thrombolytic agent to treat thrombotic disorders | |
TW200608979A (en) | Pyrrolotriazine derivatives useful for treating hyper-proliferative disorders and diseases associated with angiogenesis | |
WO2006020060A3 (en) | Iap binding compounds | |
WO2005055944A3 (en) | Oligosaccharide compositions and use thereof in the treatment of infection | |
EA200602047A1 (ru) | Сульфонилэтилфосфородиамидаты, предназначенные для применения при лечении рака | |
HUP0303917A2 (hu) | Szterin abszorpció inhibitor(ok) kombinációi vérmódosítókkal és ezek alkalmazása vaszkuláris kondíciók kezelésére | |
EP1790728A3 (en) | Imaging, diagnosis and treatment of disease | |
IL146125A0 (en) | Novel quinones as disease therapies | |
MXPA03008423A (es) | Agonistas del receptor nicotinico para el tratamiento de enfermedades inflamatorias. | |
TW200640944A (en) | VGF polypeptides and methods of treating VGF-related disorders | |
WO2003017939A3 (en) | Piperazinone compounds as anti-tumor and anti-cancer agents and methods of treatment | |
EP0281070A3 (en) | Pharmaceutical composition for the treatment of cancer | |
MXPA02000680A (es) | Polipeptidos vgf y metodos para tratar desordenes relacionados con vgf. | |
TR200200278T2 (tr) | Kalsilitik bileşimler | |
EP1234585A3 (en) | Methods and compositions for the prevention or treatment of cancer | |
DK1100824T3 (da) | Forbindelser med væksthormonfrigivende egenskaber | |
WO2002066492A3 (fr) | Anticorps specifique de l'adrenomedulline humaine, composition pharmaceutique le contenant, ses applications therapeutiques. | |
DK1253935T3 (da) | Anvendelse af placenta-vækstfaktor til forebyggelse eller behandling af iskæmiske sygdomme eller slagtilfælde | |
DK1196188T3 (da) | VGF-selektive monoklonale antistoffer og deres anvendelse til behandling af VGF-relaterede lidelser | |
UA31369A (uk) | Спосіб покращання кровотоку пілородуоденальної зони | |
UA83988C2 (ru) | Моноклональное антидвойное интегриновое антитело, которое специфически связывает человеческие интегрины альфа v бета 3 и альфа v бета 5, фармацевтическая композиция, которая его содержит, и их применение в терапии |